KAT7/HBO1/MYST2 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-KAT7/HBO1/MYST2 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | KAT7/HBO1/MYST2 |
| Clone | monoclonal |
| Host Species | Rabbit |
| Reactive Species | rat |
| Isotype | IgG |
| Format | affinity purified |
| Size | 0.03 mg, 0.1 mg, 0.1 mg |
| Concentration | n/a |
| Applications | Immunoprecipitation (IP), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: No cross reactivity with other proteins. Rabbit IgG Monoclonal antibody for O95251 detection. Tested positive for WB IHC IF/IF IP in Human Mouse Rat |
| Immunogen | Immunogen: A synthesized peptide derived from human KAT7/HBO1/MYST2 Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Through chromatin acetylation it may regulate DNA replication and act as a coactivator of TP53-dependent transcription. Specifically represses AR-mediated transcription. |
| Other Names | [histone acetyltransferase KAT7 isoform 2; Histone acetyltransferase KAT7; histone acetyltransferase KAT7; lysine acetyltransferase 7; Histone acetyltransferase binding to ORC1; Lysine acetyltransferase 7; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2; MYST-2] |
| Gene, Accession # | [KAT7], Gene ID: 11143, NCBI: NP_001186084.1, UniProt: O95251 |
| Catalog # | MBS1752303 |
| Price | $160, $340, $340 |
| Order / More Info | KAT7/HBO1/MYST2 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies